Work

Type IV collagen-derived angiogenesis inhibitors

Year: 2007

Type: review

Source: Microvascular Research

DOI: 10.1016/j.mvr.2007.05.005

Authors: Thomas M. Mundel, Raghu Kalluri

Institutions: Beth Israel Deaconess Medical Center, Harvard University, Harvard–MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Alcohol Abuse and Alcoholism, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G2512559947, G4382730148, Regulation of Angiogenesis by Tumstatin, Epigenetic Modifications in Renal Fibrogenesis, G632314946, The Biology and Function of BMP-7 in the Kidney, G6459335293, Assembly of Type IV Collagen in Health and Disease

OpenAlex ID: W2089039470

FWCI: 1.154

Cites: 64

Cited by: 194

Related to: 10